Robert W. Baker

6.7k total citations · 1 hit paper
90 papers, 4.6k citations indexed

About

Robert W. Baker is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Robert W. Baker has authored 90 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Psychiatry and Mental health, 11 papers in Cellular and Molecular Neuroscience and 11 papers in Clinical Psychology. Recurrent topics in Robert W. Baker's work include Schizophrenia research and treatment (37 papers), Bipolar Disorder and Treatment (28 papers) and Electroconvulsive Therapy Studies (26 papers). Robert W. Baker is often cited by papers focused on Schizophrenia research and treatment (37 papers), Bipolar Disorder and Treatment (28 papers) and Electroconvulsive Therapy Studies (26 papers). Robert W. Baker collaborates with scholars based in United States, United Kingdom and Canada. Robert W. Baker's co-authors include Mauricio Tohen, Richard C. Risser, Craig R. Rush, Joseph R. Calabrese, Charles L. Bowden, Alan Breier, Carlos A. Zarate, Bohdan Siryk, Angela R. Evans and Trisha Suppes and has published in prestigious journals such as Gastroenterology, American Journal of Psychiatry and Scientific Reports.

In The Last Decade

Robert W. Baker

88 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

2003 622 citations Mauricio Tohen, Joseph R. Calabrese et al. Archives of General Psychiatry profile →

Peers

Countries citing papers authored by Robert W. Baker

Since Specialization

Citations

This map shows the geographic impact of Robert W. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Baker more than expected).

Fields of papers citing papers by Robert W. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Baker. The network helps show where Robert W. Baker may publish in the future.

Co-authorship network of co-authors of Robert W. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Baker. A scholar is included among the top collaborators of Robert W. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Baker. Robert W. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation 2010 ·The Journal of Clinical Psychiatry ·Stephen R. Marder, (unknown), Eduardo Dunayevich, Jamie Karagianis, (unknown), (unknown), Mary Anne Dellva, Janice Carlson, Patrizia Cavazzoni, Robert W. Baker	39
2	Clinical Features of Bipolar Depression Versus Major Depressive Disorder in Large Multicenter Trials 2006 ·American Journal of Psychiatry ·Roy H. Perlis, Eileen Brown, Robert W. Baker, Andrew A. Nierenberg	169
3	Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia 2005 ·International Journal of Geriatric Psychiatry ·John Kennedy, Walter Deberdt, Alan P. Siegal, (unknown), Elisabeth K. Degenhardt, Jonna Ahl, Adam L. Meyers, Christopher Kaiser, Robert W. Baker	33
4	Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial 2005 ·Current Medical Research and Opinion ·Baojin Zhu, Sandra L. Tunis, Zhongyun Zhao, Robert W. Baker, Maureen J. Lage, Lizheng Shi, Mauricio Tohen	16
5	Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: Post hoc analyses of 47-week data 2005 ·Journal of Affective Disorders ·Trisha Suppes, Eileen Brown, Leslie M. Schuh, Robert W. Baker, Mauricio Tohen	33
6	Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: Post hoc analysis of patients treated with olanzapine or lithium 2005 ·Journal of Psychiatric Research ·John P. Houston, Ilya Lipkovich, Jonna Ahl, (unknown), Robert W. Baker, Charles L. Bowden	14
7	Longitudinal Effect of Olanzapine on Fasting Serum Lipids: A Randomized, Prospective, 4‐Month Study 2004 ·Annals of the New York Academy of Sciences ·Bruce J. Kinon, Hong Liu‐Seifert, Jonna Ahl, Saeeduddin Ahmed, Robert W. Baker	6
8	Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone 2004 ·The British Journal of Psychiatry ·Mauricio Tohen, K. N. Roy Chengappa, Trisha Suppes, Robert W. Baker, Carlos A. Zarate, Charles L. Bowden, Roy H. Perlis, David J. Kupfer, S. Nassir Ghaemi, Peter D. Feldman, Richard C. Risser, Angela R. Evans, Joseph R. Calabrese	214
9	Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania 2004 ·The British Journal of Psychiatry ·Robert W. Baker, Eileen Brown, Hagop S. Akiskal, Joseph R. Calabrese, Terence A. Ketter, Leslie M. Schuh, Paula T. Trzepacz, John G. Watkin, Mauricio Tohen	40
10	Acute Dysphoric Mania: Treatment Response to Olanzapine Versus Placebo 2003 ·Journal of Clinical Psychopharmacology ·Robert W. Baker, Mauricio Tohen, Jan Fawcett, Richard C. Risser, Leslie M. Schuh, Eileen Brown, Virginia L. Stauffer, Lixin Shao, Gary D. Tollefson	50
11	Olanzapine Versus Divalproex in the Treatment of Acute Mania 2002 ·American Journal of Psychiatry ·Mauricio Tohen, Robert W. Baker, Lori L. Altshuler, Carlos A. Zarate, Trisha Suppes, T A Ketter, Denái R. Milton, Richard C. Risser, J. A. Gilmore, Alan Breier, (unknown)	187
12	Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania 2002 ·Journal of Affective Disorders ·Robert W. Baker, Denái R. Milton, Virginia L. Stauffer, Alan J. Gelenberg, Mauricio Tohen	12
13	Efficacy of Olanzapine in Combination With Valproate or Lithium in the Treatment of Mania in Patients Partially Nonresponsive to Valproate or Lithium Monotherapy 2002 ·Archives of General Psychiatry ·Mauricio Tohen, K. N. Roy Chengappa, Trisha Suppes, Carlos A. Zarate, Joseph R. Calabrese, Charles L. Bowden, Roy H. Perlis, David J. Kupfer, Robert W. Baker, Richard C. Risser, (unknown), Peter D. Feldman, Gary D. Tollefson, Alan Breier	290
14	A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data 2001 ·International Journal of Geriatric Psychiatry ·John Kennedy, Frank P. Bymaster, Leslie M. Schuh, David O. Calligaro, George G. Nomikos, Christian C. Felder, (unknown), Bruce J. Kinon, Robert W. Baker, Donald P. Hay, Helmut Roth, Martín Dossenbach, Christopher Kaiser, Charles M. Beasley, John H. Holcombe, Mark B. Effron, Alan Breier	29
15	Zolpidem and triazolam interact differentially with a delay interval on a digit‐enter‐and‐recall task 2001 ·Human Psychopharmacology Clinical and Experimental ·Craig R. Rush, Robert W. Baker	9
16	Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. 2001 ·Experimental and Clinical Psychopharmacology ·Craig R. Rush, Robert W. Baker	70
17	Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans. 2000 ·Experimental and Clinical Psychopharmacology ·Craig R. Rush, Robert W. Baker, James K. Rowlett	16
18	An evaluation of ‘rapid review’ as a method of quality control of cervical smears using the AxioHOME microscope 1997 ·Cytopathology ·Robert W. Baker, Jonathan D. F. Wadsworth, G Brugal, D. V. Coleman	11
19	Assessing Slide Coverage by Cytoscreeners during the Primary Screening of Cervical Smears, Using the AxioHOME^Ⓡ Microscope System 1996 ·Analytical Cellular Pathology ·Robert W. Baker, G Brugal, Dulcie V. Coleman	1
20	Alprazolam withdrawal delirium unresponsive to diazepam: case report. 1985 ·PubMed ·R.B. Zipursky, Robert W. Baker, Benjamin Zimmer	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact